Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 82959481

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient Alirocumab (C10AX14) within the period from August 1, 2024 to July 31, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Alirocumab (C10AX14) im Rahmen eines sogenannten Open-House-Mo

Gt Ref Id - 82959481

Deadline - May 31, 2026